Bayer will discontinue the marketing and sales of the sterilization device Essure in all countries outside of the United States, the company announced on Monday. While a number of reports have linked ...

But it is business as usual in the U.S. for the device plagued by lawsuits and allegations of harm. The North American headquarters of Bayer Healthcare in Whippany, New Jersey. The U.S. Food and Drug ...

WASHINGTON — U.S. health officials on Monday placed new restrictions on a permanent contraceptive implant that has been subject to reports of painful complications from thousands of women. But the ...

WASHINGTON (AP) – Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that drew thousands of complaints from women reporting chronic pain, bleeding and ...

WASHINGTON (AP) — Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression ...

Pharmaceutical giant Bayer said Friday that it will halt sales of its controversial Essure birth-control device in the United States at the end of the year, bringing to a close a protracted battle ...

Essure birth control was first approved in 2002. — -- U.S. regulators said they would review a popular birth control implant device at a panel this week following multiple complaints. The implant ...

Pharmaceutical giant Bayer said Friday that it will halt sales of its controversial Essure birth-control device in the United States at the end of the year, bringing to a close a protracted battle ...

The pharma company said the decision was based on poor sales, not health risks. Editor's Note: After the July 26, 2018 "Good Morning America" broadcast report, Bayer provided us with a statement which ...

WASHINGTON (AP) — Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that has drawn thousands of complaints from women reporting chronic pain, ...